Home › Funds › Affinity Asset Advisors, LLC › ABVX

Affinity Asset Advisors, LLC position in ABVX

ABIVAX SA · Health Care

Affinity Asset Advisors, LLC reported holding 330,000 shares of ABVX (ABIVAX SA) in its Q3 2026 13F filing — a position valued at US$32.7M, representing 1.52% of its reported portfolio and ranking #17 among its reported holdings. Affinity Asset Advisors, LLC has disclosed ABVX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)330.00K sh
Reported value held$32.68M
Portfolio Weight1.52%
First reportedQ1 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's ABVX position evolved

Affinity Asset Advisors, LLC first disclosed a stake in ABVX in Q1 2025 at 200,000 shares (US$1.2M). The position peaked in Q4 2025 at 505,000 shares, worth US$68.1M. Across 7 filings, Affinity Asset Advisors, LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 330,000 shares valued at US$32.7M. Notable position changes include a 50% trim in Q2 2025 (shares rose 1010% over the following quarter), a 260% increase in Q3 2025 (shares rose 59% over the following quarter), a 40% increase in Q4 2025 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 200.00K $1.25M New
Q2 2025 100.00K $765.00K Reduce
Q3 2025 360.00K $30.56M Add
Q4 2025 505.00K $68.10M Add
Q1 2026 405.00K $45.10M Reduce
Q2 2026 330.00K $43.98M Reduce
Q3 2026 330.00K $32.68M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 70 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$418.2M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held ABVX?

Affinity Asset Advisors, LLC has disclosed ABVX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Affinity Asset Advisors, LLC's current position in ABVX?

As of Q3 2026, Affinity Asset Advisors, LLC holds 330.00K shares of ABVX (ABIVAX SA), valued at $32.68M, representing 1.52% of its reported portfolio and ranking #17.

Has Affinity Asset Advisors, LLC been buying or selling ABVX?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC held unchanged its position in ABVX. The position peaked in Q4 2025 at 505.00K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.